EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
28/04/2026
Voltar para busca
Dado oficial do USPTO
HUNTSMAN CANCER INSTITUTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HUNTSMAN CANCER INSTITUTE
ST13
US500000085080761Classe
41, 42, 44
Pedido
85080761
Registro
4394527
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
30/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
41, 42, 44
Data de depósito
08/07/2010
Data de registro
03/09/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/02/2025
Última transação
30/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
30/09/1997
Primeiro uso no comércio
30/09/1997
Código do desenho
4
Tipo de titular
37
Localização do titular
Salt Lake City, UT, US
Examinador
SHARPER JR, SAM
Localização atual
Historical data usage
Titulares e representantes
Titulares
T. U. (pessoa física)
Representantes
Lester K. Essig Ray Quinney & Nebeker
Classificação técnica
Classes Nice
Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Educational servicesproviding seminarsclassesconferenceslecturesworkshops in the fields of sciencemedicinegeneticscancercancer awarenesscancer researchcancer testingcancer diagnosiscancer preventioncancer treatmentcancer patient and family support; learning center services in the fields of sciencemedicinegeneticscancercancer awarenesscancer researchcancer testingcancer diagnosiscancer preventioncancer treatmentcancer patient and family support; and library services in the fields of sciencemedicinegeneticscancercancer awarenesscancer researchcancer testingcancer diagnosiscancer preventioncancer treatmentcancer patient and family support
Classe 42
Research and testing in the fields of sciencemedicinegeneticscancercancer diagnosiscancer preventioncancer treatment; providing medical and scientific research information and on-line information and consultation in the fields of genetic sciencecancercancer awarenesscancer research; providing medical testing services and information in the field of cancer research; and computer servicesproviding search engines for obtaining data on a global computer network in the fields of sciencemedicinegeneticscancercancer awarenesscancer researchcancer testingcancer diagnosiscancer preventioncancer treatmentcancer patient and family support
Classe 44
Medical services; medical testing for diagnostic and treatment purposes in the field of cancer; genetic testing for medical purposes and genetic counseling in the field of cancer; medical diagnostic reporting services; health care services; hospital services for persons with cancer; clinical medical test servicesconducting clinical trials; medical imaging services; medical radiology services; medical chemotherapy services; surgery services; providing medical servicesmedical testing for diagnostic and treatment purposes; providing medical servicesmedical testing for diagnostic and treatment purposes for the uninsured and underinsured; medical recovery services; medical rehabilitation servicesphysical rehabilitation and rehabilitation patient care services; providing medical services in the fields of geneticscancercancer diagnosiscancer preventioncancer treatmentcancer patient and family support; preparation and dispensing of medications; providing medical information and consultation in the fields of medicinegeneticscancercancer awarenesscancer testingcancer diagnosiscancer preventioncancer treatmentvolunteer programspatient reportscancer patient and family support; on-line medical information services in the fields of medicinegeneticscancercancer awarenesscancer testingcancer diagnosiscancer preventioncancer treatmentvolunteer programspatient reportscancer patient and family support
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/04/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
16/09/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
22/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/08/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
18/03/2025
PC.D
PETITION TO DIRECTOR DISMISSED
07/02/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/02/2025
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/02/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/02/2025
REIN
REINSTATED
03/02/2025
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
21/01/2025
PILM
PETITION INQUIRY LETTER ISSUED
19/12/2024
APET
ASSIGNED TO PETITION STAFF
02/12/2024
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
18/09/2024
NCS8
NOTICE OF CANCELLATION SEC. 8 EMAILED
07/09/2024
C8.T
CANCELLED SEC. 8 (10-YR)
07/09/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
24/02/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/02/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
31/08/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/09/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/10/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/10/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/09/2019
E815
TEAS SECTION 8 & 15 RECEIVED
03/09/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/09/2013
PUBO
PUBLISHED FOR OPPOSITION
18/06/2013
NPUB
NOTICE OF PUBLICATION
29/05/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/05/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2013
ACEC
AMENDMENT FROM APPLICANT ENTERED
30/04/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/04/2013
PAPER RECEIVED
23/04/2013
PAPER RECEIVED
15/04/2013
CNRT
NON-FINAL ACTION MAILED
11/10/2012
CNRT
NON-FINAL ACTION WRITTEN
10/10/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
19/09/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/09/2012
PAPER RECEIVED
17/08/2012
CNRT
NON-FINAL ACTION MAILED
15/02/2012
CNRT
NON-FINAL ACTION WRITTEN
15/02/2012
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
27/01/2012
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
17/01/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/01/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
13/12/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2011
PAPER RECEIVED
05/12/2011
CNFR
FINAL REFUSAL MAILED
03/06/2011
CNFR
FINAL REFUSAL WRITTEN
02/06/2011
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/05/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2011
ALIE
ASSIGNED TO LIE
05/05/2011
PAPER RECEIVED
29/04/2011
CNRT
NON-FINAL ACTION MAILED
27/10/2010
CNRT
NON-FINAL ACTION WRITTEN
27/10/2010
DOCK
ASSIGNED TO EXAMINER
20/10/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
14/07/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/07/2010
NWAP
NEW APPLICATION ENTERED
12/07/2010
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HUNTSMAN CANCER INSTITUTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.